MétaCan
Menu
Back to cohort
Record W4400439918 · doi:10.1016/s2665-9913(24)00117-6

Global, regional, and national burden of gout, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021

2024· article· en· W4400439918 on OpenAlexfundno aff
Marita Cross, Kanyin Liane Ong, Garland T Culbreth, Jaimie D Steinmetz, Ewerton Cousin, Hailey Lenox, Jacek A Kopec, Peter Brooks, Deborah Kopansky-Giles, Karsten E Dreinhoefer, Neil Betteridge, Mohammadreza Abbasian, Mitra Abbasifard, Aidin Abedi, Melka Biratu Aboye, Aleksandr Y. Aravkin, Al Artaman, Maciej Banach, Isabela M. Benseñor, Akshaya Srikanth Bhagavathula, Ajay Nagesh Bhat, Saeid Bitaraf, Rachelle Buchbinder, Katrin Burkart, Dinh‐Toi Chu, Sheng‐Chia Chung, Omid Dadras, Xiaochen Dai, Saswati Das, Sameer Dhingra, Thanh Chi, Hisham Atan Edinur, Ali Fatehizadeh, Getahun Fetensa, Marisa Freitas, Balasankar Ganesan, Ali Gholami, Tiffany K. Gill, Mahaveer Golechha, Pouya Goleij, Nima Hafezi‐Nejad, Samer Hamidi, Simon I Hay, Samuel Hundessa, Hiroyasu Iso, Shubha Jayaram, Vidya Kadashetti, Ibraheem M. Karaye, Ejaz Ahmad Khan, Moien AB Khan, Moawiah Khatatbeh, Ali Kiadaliri, Min Seo Kim, Ali‐Asghar Kolahi, Kewal Krishan, Narinder Kumar, Thao T. Le, Stephen S Lim, Stany W. Lobo, Azeem Majeed, Ahmad Azam Malik, Mohamed Kamal Mesregah, Tomislav Meštrović, Erkin М Мirrakhimov, Manish Mishra, Arup Kumar Misra, Madeline E Moberg, Nouh Saad Mohamed, Syam Mohan, Ali H. Mokdad, Kaveh Momenzadeh, Mohammad Ali Moni, Yousef Moradi, Vincent Mougin, Satinath Mukhopadhyay, Christopher J L Murray, Sreenivas Narasimha Swamy, Văn Thành Nguyễn, Robina Khan Niazi, Mayowa Owolabi, Jagadish Rao Padubidri, Jay Patel, Shrikant Pawar, Paolo Pedersini, Quinn Rafferty, Mosiur Rahman, Mohammad‐Mahdi Rashidi, Salman Rawaf, Aly M A Saad, Amirhossein Sahebkar, Fatemeh Saheb Sharif‐Askari, Mohamed A. Saleh, Austin E Schumacher, Allen Seylani, Paramdeep Singh, Amanda Smith, Ranjan Solanki, Yonatan Solomon, Ker‐Kan Tan, Nathan Y Tat, Nigusie Selomon Tibebu, Yuyi You, Peng Zheng, Osama A. Zitoun, Theo Vos, Lyn March, Anthony D. Woolf

Bibliographic record

VenueThe Lancet Rheumatology · 2024
Typearticle
Languageen
FieldMedicine
TopicGout, Hyperuricemia, Uric Acid
Canadian institutionsnot available
FundersMedical Research CouncilZayed UniversityUniversidade do PortoShahid Beheshti University of Medical SciencesUniwersytet ŁódzkiUniversidade de São PauloKermanshah University of Medical SciencesMonash UniversityJimma UniversityAhvaz Jundishapur University of Medical SciencesUniversiti Sains MalaysiaNational Institute of Pharmaceutical Education and Research, RaebareliUniversity of TorontoUniversity of Southern CaliforniaUniversity College LondonWollega UniversityFederation University AustraliaJohns Hopkins UniversityUniversity of WashingtonNeyshabur University of Medical SciencesIsfahan University of Medical SciencesHarvard UniversityNorth Dakota State UniversityUniversitetet i BergenNational Institute for Health and Care ResearchLaboratório Associado para a Química VerdeRafsanjan University of Medical SciencesTehran University of Medical Sciences and Health ServicesBill and Melinda Gates Foundation
KeywordsGoutMedicineDemographyDisease burdenPopulationBurden of diseaseEnvironmental healthDiseaseInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND: Gout is an inflammatory arthritis manifesting as acute episodes of severe joint pain and swelling, which can progress to chronic tophaceous or chronic erosive gout, or both. Here, we present the most up-to-date global, regional, and national estimates for prevalence and years lived with disability (YLDs) due to gout by sex, age, and location from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021, as well as forecasted prevalence to 2050. METHODS: Gout prevalence and YLDs from 1990 to 2020 were estimated by drawing on population-based data from 35 countries and claims data from the USA and Taiwan (province of China). Nested Bayesian meta-regression models were used to estimate prevalence and YLDs due to gout by age, sex, and location. Prevalence was forecast to 2050 with a mixed-effects model. FINDINGS: In 2020, 55·8 million (95% uncertainty interval 44·4-69·8) people globally had gout, with an age-standardised prevalence of 659·3 (525·4-822·3) per 100 000, an increase of 22·5% (20·9-24·2) since 1990. Globally, the prevalence of gout in 2020 was 3·26 (3·11-3·39) times higher in males than in females and increased with age. The total number of prevalent cases of gout is estimated to reach 95·8 million (81·1-116) in 2050, with population growth being the largest contributor to this increase and only a very small contribution from the forecasted change in gout prevalence. Age-standardised gout prevalence in 2050 is forecast to be 667 (531-830) per 100 000 population. The global age-standardised YLD rate of gout was 20·5 (14·4-28·2) per 100 000 population in 2020. High BMI accounted for 34·3% (27·7-40·6) of YLDs due to gout and kidney dysfunction accounted for 11·8% (9·3-14·2). INTERPRETATION: Our forecasting model estimates that the number of individuals with gout will increase by more than 70% from 2020 to 2050, primarily due to population growth and ageing. With the association between gout disability and high BMI, dietary and lifestyle modifications focusing on bodyweight reduction are needed at the population level to reduce the burden of gout along with access to interventions to prevent and control flares. Despite the rigour of the standardised GBD methodology and modelling, in many countries, particularly low-income and middle-income countries, estimates are based on modelled rather than primary data and are also lacking severity and disability estimates. We strongly encourage the collection of these data to be included in future GBD iterations. FUNDING: Bill & Melinda Gates Foundation and the Global Alliance for Musculoskeletal Health.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.013
metaresearch head score (Gemma)0.017
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Meta-analysis · Consensus signal: Meta-analysis
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.043
Threshold uncertainty score0.085

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0130.017
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0040.016
Bibliometrics0.0060.008
Science and technology studies0.0000.001
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.025
GPT teacher head0.322
Teacher spread0.297 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designMeta-analysis
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations214
Published2024
Admission routes1
Has abstractyes

Explore more

Same venueThe Lancet RheumatologySame topicGout, Hyperuricemia, Uric AcidFrench-language works237,207